Premium
Invited Speakers
Author(s) -
Benjamin Burton,
David Gabai
Publication year - 2018
Publication title -
clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 1442-6404
DOI - 10.1111/ceo.13399
Subject(s) - medicine , audiology
s remains with the authors. everyday practise can use the registries. Following a ‘world first’ stem cell treatment that restored the corneal surface and improved sight, using a unique model, new knowledge of stem cell biology has allowed us to optimise this treatment. A RANZCO position statement on Ocular Stem Cells has informed the public on the current state of stem cell treatments. The public were also alerted to Vitamin A deficiency in Australian children and adults. For corneal infections a surveillance programme, Orthokeratology advice, and an international collaboration have been developed. An international study is looking towards prevention for ocular trauma. For tomorrow, supporting research along with training the next generation of eye experts – clinicians and scientists, will allow continued provision of the best care to our patients. Brief Curriculum Vitae: Professor Stephanie Watson is corneal and cataract surgeon with appointments at the Save Sight Institute, University of Sydney and Sydney Eye, Prince of Wales, and Sydney Children’s Hospitals. She is in practice in Bondi Junction, Sydney. Prof Watson leads a research program focused on innovative solutions to restore sight and promote eye health; and trains the next generation of eye care workers and researchers. Prof Watson is recognised internationally for her ground-breaking corneal therapies; including a world-first stem cell transplantation technique. She has over 152 publications; has given over 175 presentations and been appointed as a Visiting Professor nationally and internationally. Her career has been supported by the National Health and Medical Research Council. As Chair of the Ophthalmic Research Institute of Australia; Stem Cells Australia Regenerative Medicine Programme representative; and Editor, Cochrane Eyes and Vision Group UK she contributes to policy development. Prof Watson was selected by the University of Sydney and completed the Chief Executive Women leaders programme and has completed the ARVO Leadership development programme for Women. She is a member of the ARVO, Advocacy and Outreach Committee. ARVO is the largest and most respected eye and vision research organisation in the world. Awards received include first prize on the Medical Device Commercialisation Training Program, NSW Women of the Year and Pride of Australia nominations, UNSW Early stage innovation award finalist, Gustav Nossal NHMRC scholarship – awarded to the highest ranked applicant, and the ‘Les is more’ grand final and people’s choice award on The New Inventors. Contact Details: The University of Sydney, Save Sight Institute, Australia Email: stephanie.watson@sydney.edu.au L03: CORNEA UPDATE LECTURE, SUNDAY 18 NOVEMBER 2018 J Bradley Randleman, MD Measuring and Managing Corneal Biomechanics